Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Kura Oncology, Inc.

Kura Oncology, Inc.

Stage unknownSan Diego, CAkuraoncology.comBiotechnology

Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.

Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Jan 26, 2024
    Form D equity offering · $150M (form d sold) · 10 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Kura Oncology, Inc. filed Form D: $150,000,808 sold of $150,000,808, Biotechnology”
Investors on record
2 edges
People
5 officers, 6 directors
Timeline
1
  1. Feb 5, 2024
    Kura Oncology, Inc. filed Form D: $150,000,808 sold of $150,000,808, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
21 observations
Every observation on this company